FDA-Inspected Site

Genus Lifesciences Inc.

2 FDA inspections are on record for Genus Lifesciences Inc. in Allentown, United States.

483· Form 483 issued

Allentown, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2024-12-13.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Dec 2024 – 13 Dec 2024Human Drugs483View 483 →
20 Jul 2021 – 23 Jul 2021Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

13 Dec 2024
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Mindy M Chou, Evan Tong, Paige R Mccoy, Azeezat M Lawal

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Genus Lifesciences Inc.'s 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat